BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-02-27
• Last 15 days FTD volume: S$0.89 M
• Last 3 months FTD volume: S$1.66 M
• Last 12 months FTD volume: S$6.1 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	S$27.51 M	S$0.26 B	🇺🇸 USA
GSK plc GSK	S$28.21 M	S$0.27 B	🇬🇧 UK
Sarepta Therapeutics SRPT	S$4.82 M	S$23.17 M	🇺🇸 USA
Repligen RGEN	S$7.33 M	S$19.36 M	🇺🇸 USA
Novavax NVAX	S$16.71 M	S$66.22 M	🇺🇸 USA
Celldex Therapeutics CLDX	S$1.83 M	S$11.81 M	🇺🇸 USA
NanoViricides NNVC	S$0.01 M	S$4.13 M	🇺🇸 USA
Cel-Sci CVM	N/A	S$0.31 M	🇺🇸 USA
Emergent BioSolutions EBS	S$0.18 M	S$3.67 M	🇺🇸 USA